ST. JOSEPH, Mich., May 15 /PRNewswire/ -- GeneGo, Inc., a leading provider of software and databases for systems biology, today announced that Peakadilly NV, Belgium, has licensed MetaCore for use in proteomics research. MetaCore will be available via the intranet to Peakadilly. It was important to Peakadilly that MetaCore content covers multiple levels of protein interactions from extra cellular stimuli through signaling to core metabolism and that MetaCore is well designed for proteomics research.
“We were impressed by the quality of the content and unique capabilities of the visualization and analysis software in MetaCore,” said Dr Koen Kas, CSO of Peakadilly.
“We are very happy that Peakadilly, well known for its innovative and high performance proteomics technologies, has chosen MetaCore as a functional analysis engine. We will be working closely with them as we further develop our proteomics offering,” said Julie Bryant, Vice President of Business Development at GeneGo. “Compared to genomics, proteomics data is more complex, yet they provide unique insights about active cell machinery. Proteomics data mining is an important area in our technology development and one for which we have been awarded government grants.”
About GeneGo
GeneGo develops systems biology technology for life science research. The original computational platform allows an integration and expert analysis of different kinds of experimental data (mRNA expression, proteomics, metabolomics, siRNA and other phenotypic data) and relevant bioactive chemistry (metabolites, drugs, other xenobiotics) within the framework of curated biological pathways and networks. GeneGo’s flagship product, MetaCore 3.2, assists pharmaceutical scientists in the areas of target selection and validation, identification of biomarkers for disease states and toxicology. The second product, MetaDrug(TM) is designed for prediction of human metabolism, toxicity and biological effects for novel small molecules compounds. MetaBase(TM) represents the knowledge base for MetaCore. For more information, please visit the company’s web site at www.genego.com.
MetaCore(TM), MetaBase(TM) and MetaDrug(TM) are trademarks of GeneGo, Inc.
About Peakadilly
Peakadilly was founded in late 2004 to exploit the protein biomarker discovery technology developed at VIB and the University of Ghent. In this short time, it has successfully implemented the technology and won revenue generating projects with big pharma. It applies the technology both to third party projects and to its own projects for developing a new generation of diagnostics and pharmacodiagnostic products.
GeneGo, Inc.
CONTACT: Julie Bryant, VP Business Development and Marketing of GeneGo,Inc., +1-858-756-7996, julie@genego.com
Web site: http://www.genego.com//
